List of works - Marta Fernandez-Mercado

Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms

scientific article published on 25 November 2020

Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells

scientific article published on 27 November 2014

Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.

scientific article published on 20 March 2012

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

article

Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma

scientific article published on 20 November 2020

Methylation status of SOCS1 and SOCS3 in BCR-ABL negative and JAK2V617F negative chronic myeloproliferative neoplasms

scientific article published on 25 April 2008

Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics

scientific article

Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma

scientific article published on 26 April 2018

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.

scientific article published on 24 July 2013

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34⁺ progenitor cells

scientific article

TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia

scientific article

Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes

scientific article published on 01 January 2014

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes

scientific article published on 05 July 2013

Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression.

scientific article published on 20 May 2015

The Circulating Transcriptome as a Source of Biomarkers for Melanoma

scientific article published on 10 January 2019

The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients

scientific article published on 19 August 2018

The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts

scientific article published on 16 October 2012

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia

scientific article published on 24 December 2013

List of works by Marta Fernandez-Mercado

Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms

Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells

Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia

Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma

Methylation status of SOCS1 and SOCS3 in BCR-ABL negative and JAK2V617F negative chronic myeloproliferative neoplasms

Mutation patterns of 16 genes in primary and secondary acute myeloid leukemia (AML) with normal cytogenetics

Mutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinoma

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.

Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34⁺ progenitor cells

TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia

Targeted next-generation sequencing and non-coding RNA expression analysis of clear cell papillary renal cell carcinoma suggests distinct pathological mechanisms from other renal tumour subtypes

Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes

Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progression.

The Circulating Transcriptome as a Source of Biomarkers for Melanoma

The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients

The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts

Whole-exome sequencing in del(5q) myelodysplastic syndromes in transformation to acute myeloid leukemia